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ABSTRACT
Antimicrobial resistance is a current and important issue to public health, and it is usually associated with the indiscriminate 
use of antimicrobials in animal production. This study aimed to evaluate the antimicrobial susceptibility profile in bacterial 
isolates from pigs with clinical respiratory signs in Brazil. One hundred sixty bacterial strains isolated from pigs from 51 pig 
farms in Brazil were studied. In vitro disk-diffusion method was employed using 14 antimicrobial agents: amoxicillin, penicillin, 
ceftiofur, ciprofloxacin, enrofloxacin, chlortetracycline, doxycycline, oxytetracycline, tetracycline, erythromycin, tilmicosin, 
florfenicol, lincomycin, and sulfadiazine/trimethoprim. The majority of isolates were resistant to at least one antimicrobial 
agent (98.75%; 158/160), while 31.25% (50/160) of the strains were multidrug resistant. Streptococcus suis and Bordetella 
bronchiseptica were the pathogens that showed higher resistance levels. Haemophilus parasuis showed high resistance levels 
to sulfadiazine/trimethoprim (9/18=50%). We observed that isolates from the midwestern and southern regions exhibited 
four times greater chance of being multidrug resistant than the isolates from the southeastern region studied. Overall, the 
results of the present study showed a great level of resistance to lincomycin, erythromycin, sulfadiazine/trimethoprim, and 
tetracycline among bacterial respiratory pathogens isolated from pigs in Brazil. The high levels of antimicrobial resistance in 
swine respiratory bacterial pathogens highlight the need for the proper use of antimicrobials in Brazilian pig farms.
Keywords: Multidrug resistance. Streptococcus suis. Pasteurella multocida. Haemophilus parasuis. Actinobacillus 
pleuropneumoniae. Bordetella bronchiseptica.
RESUMO
A resistência antimicrobiana é uma questão atual e muito importante para a saúde pública, geralmente associada ao uso 
indiscriminado de antimicrobianos na produção animal. Diante disso, foi investigado o perfil de sensibilidade-antimicrobiana em 
isolados bacterianos de suínos com sinais clínicos respiratórios no Brasil. Foram estudadas 96 isolados provenientes de 51 granjas 
de suínos do Brasil. O método de disco-difusão foi empregado usando 14 antimicrobianos: amoxicilina, penicilina, ceftiofur, 
ciprofloxacina, enrofloxacina, clortetraciclina, doxiciclina, oxitetraciclina, tetraciclina, eritromicina, tilmicosina, florfenicol, 
lincomicina e sulfadiazina/trimetoprim. Streptococcus suis e Bordetella bronchiseptica foram os patógenos que apresentaram 
maiores níveis de resistência. Haemophilus parasuis apresentou altos níveis de resistência à sulfadiazina/trimetoprim (9/18=50%). 
Observou-se que isolados das regiões Centro-Oeste e Sul apresentaram quatro vezes mais chance de serem multirresistentes 
do que os isolados da região Sudeste. A maioria foi resistente a pelo menos um agente antimicrobiano (98,75%; 158/160) e 
31,25% (50/160) das estirpes isoladas eram multirresistentes. No geral, os resultados do presente estudo mostraram grande nível 
de resistência à lincomicina, eritromicina, sulfadiazina/trimetoprim e tetraciclina entre patógenos respiratórios bacterianos 
isolados de suínos no Brasil. Os altos níveis de resistência antimicrobiana em patógenos bacterianos respiratórios em suínos 
reforçam a necessidade do uso criterioso de antimicrobianos na suinocultura brasileira.
Palavras-chave: Resistência múltipla aos antimicrobianos. Streptococcus suis. Pasteurella multocida. Haemophilus 
parasuis. Actinobacillus pleuropneumoniae. Bordetella bronchiseptica.
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Introduction
Currently, swine is the main source of protein consumed 
worldwide and Brazil is the fourth largest producer 
and exporter of these animals (Associação Brasileira de 
Proteína Animal, 2018). To meet the growing demand for 
swine, intensive systems have been increasingly used and, 
consequently, the risk of infectious diseases becomes greater 
(Heres  et  al., 2013). Animal density and other adverse 
conditions favor the introduction and dissemination of 
respiratory disease agents (Dayao et al., 2014).
Respiratory diseases in pigs are multifactorial pathologies 
influenced by the interaction of several microorganisms, 
in addition to genetic and environmental factors, which 
cause significant decreases in production and productivity, 
resulting in high economic losses for pig farms (Jong et al., 
2014; El Garch et al., 2016). The bacterial agents associated 
with respiratory clinical signs are often commensal and 
opportunistic bacteria of the respiratory tract that play an 
important role in the infection, exacerbating the clinical signs 
and causing more severe lesions (Opriessnig et al., 2011). 
Among the most important bacterial pathogens involved 
in swine respiratory diseases are Pasteurella multocida, 
Streptococcus suis, Haemophilus parasuis, Actinobacillus 
pleuropneumoniae, Mycoplasma hyopneumoniae, and 
Bordetella bronchiseptica (Opriessnig et al., 2011; Jong et al., 
2014; Dayao et al., 2016).
Control of these respiratory infections in pigs is usually 
performed by administering antimicrobials. However, 
the indiscriminate use of these drugs can lead to a rapid 
selection and dissemination of resistance among bacterial 
pathogens. The increasing level of multidrug resistant 
(MDR) bacteria is a potential risk to public health 
and may hinder the treatment of animal and human 
infections (Jong  et  al., 2014). Thus, this study aimed 
to evaluate the antimicrobial susceptibility profile of 
bacterial pathogens isolated from pigs with respiratory 
clinical signs in Brazil.
Materials and Methods
This study used non-probabilistic sampling obtained from 
data of a private laboratory. One hundred sixty bacterial 
strains isolated from pigs with clinical respiratory signs from 
51 pig farms in Brazil were studied, as follows: P. multocida 
[78/160 (48.75%)] S. suis [42/160 (26.25%)], H. parasuis 
[18/160 (11.25%)], A. pleuropneumoniae [17/160 (10.62%)], 
and B. bronchiseptica [5/160 (3.12%)]. Clinical samples 
were collected by veterinary practitioners between May 
2006 and November 2007 and processed by a private 
veterinary diagnostic laboratory (Institute of Specialized 
Veterinary Research (IPEVE), Belo Horizonte, Brazil). The pig 
farms were from nine Brazilian states in the midwestern, 
southeastern and southern regions, comprising the major 
swine production areas in the country. The distribution of 
isolates by Brazilian state and region is shown in Table 1.
In vitro antimicrobial susceptibility tests were 
performed by the disk-diffusion method in accordance 
with the recommendations of the Clinical and Laboratory 
Standards Institute (CLSI) M132-A2 manual (National 
Committee for Clinical Laboratory Standards, 2002), and 
the isolates were classified as resistant, intermediate, or 
susceptible according to the following references: CLSI 
manuals supplement VET08 and M100 (Clinical Laboratory 
Standards Institute, 2018a, b), EUCAST, CLSI-potency 
Neo-Sensitabs™ User’s Guide (Rosco Diagnostica, 2013), 
Lönnqvist et al. (2018), and Kim et al. (2016). The breakpoints 
used are detailed in the supplementary material. 
Multidrug resistance (MDR) was defined as resistance 
to three or more antimicrobial groups (Magiorakos et al., 
2011). The following antimicrobial groups were tested: 
1) penicillins (amoxicillin 10 µg and penicillin G 10 µg); 
2) cephalosporins (ceftiofur 30 µg); 3) fluoroquinolones 
(enrofloxacin 5 µg and ciprofloxacin 5 µg); 4) tetracyclines 
(tetracycline 30 µg, chlortetracycline 10 µg, doxycycline 30 µg 
and oxytetracycline 30 µg); 5) macrolides (erythromycin 
30 µg, and tilmicosin 15 µg); 6) amphenicols (florfenicol 
30 µg); 7) lincosamides (lincomycin 2 µg), and 8) folate 
pathway inhibitors (sulfadiazine + trimethoprim 25 µg). 
Isolates were tested for different antimicrobial agents 
according to the bacterial species and the request of the 
pig farm veterinarian. The antimicrobial agents tested in 
90% or more bacterial isolates were amoxicillin, ceftiofur, 
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ciprofloxacin, doxycycline, enrofloxacin, florfenicol, 
lincomycin, sulfadiazine/trimethoprim, and penicillin.
Data from all 160 consecutive samples of pigs with 
respiratory disorders were collected from the laboratory 
recording files and organized in a database using Microsoft 
Office Excel 2007 (Redmond, WA, USA). Descriptive analyses 
of the antimicrobial susceptibility profile of the strain and 
location of pig farm, season, and bacterial species isolated 
were performed. The Chi-square test and the odds ratio were 
calculated using the EpiInfo™ software version 7.2.2.6 (Centers 
for Disease Control and Prevention [CDC], USA).
Results
The percentages of isolates classified as resistant, 
intermediate or susceptible for each antimicrobial are shown 
in Table 2. Resistance of the isolates was observed mainly 
to lincomycin, erythromycin, sulfadiazine/trimethoprim, 
and tetracyclines.
Susceptibility profiles were constructed for each 
bacterial species based on the antimicrobial groups. Only 
the antimicrobial groups that were tested for all strains of 
the species were used for the construction of those profiles 
(Table 3). Twenty-eight profiles were observed for P. multocida, 
17 for S. suis, 10 for H. parasuis, 9 for A. pleuropneumoniae, 
and 1 for B. bronchiseptica. (Figure 1).
A comparison of the resistance levels of bacterial species 
isolated from pig respiratory disorders by antimicrobial groups 
among the Brazilian regions is shown in Figure 2. S. suis 
showed higher levels of resistance compared to P. multocida, 
A. pleuropneumoniae and H. parasuis. For H. parasuis, 
resistance was observed mostly to sulfadiazine/trimethoprim. 
All B. bronchiseptica strains exhibited resistance to five 
Table 1. Bacterial species isolated from tissue samples of pigs with respiratory clinical signs from nine Brazilian states, between 
May 2006 and November 2007







MG 35 14 11 9 1 71
MT 15 6 2 2 0 25
MS 5 3 1 6 1 16
GO 2 7 1 0 3 13
SC 6 2 3 0 0 11
RS 2 8 0 0 0 10
SP 5 2 0 0 0 7
PR 4 0 0 0 0 4
ES 4 0 0 0 0 4
Total 78 42 18 17 5 160
aMinas Gerais (MG); Mato Grosso (MT); Mato Grosso do Sul (MS); Goiás (GO); Santa Catarina (SC); Rio Grande do Sul (RS); São Paulo (SP); Paraná (PR); 
Espírito Santo (ES). Midwest region states (MT, MS, GO); Southeast region states (MG, SP, ES); South region states (SC, PR, RS).
Table 2. Antimicrobial susceptibility of bacterial pathogens isolated from pigs with respiratory clinical signs, between May 2006 










aR% bS% cI% R% S% I% R% S% I% R% S% I% R% S% I%
Amoxicillin 0.00 88.24 11.76 0.00 100.00 0.00 100.00 0.00 0.00 3.84 94.88 1.28 0.00 100.00 0.00
Penicillin 11.76 76.47 11.76 2.38 95.24 2.38 100.00 0.00 0.00 0.00 92.31 7.69 5.56 94.44 0.00
Ceftiofur 0.00 100.00 0.00 0.00 100.00 0.00 dNT 1.28 97.44 1.28 0.00 100.00 0.00
Ciprofloxacin 11.76 88.24 0.00 30.95 50.00 19.05 0.00 80.00 20.00 2.56 96.16 1.28 0.00 100.00 0.00
Enrofloxacin 11.76 82.35 5.88 7.14 59.52 33.33 0.00 60.00 40.00 1.28 85.90 12.82 11.11 88.89 0.00
Chlortetracycline 0.00 81.82 18.18 73.08 7.69 19.23 NT 16.07 78.57 5.36 0.00 90.91 9.09
Doxycycline 0.00 94.12 5.88 28.57 38.10 33.33 NT 3.84 96.16 0.00 0.00 100.00 0.00
Oxytetracycline 36.36 18.18 45.45 57.69 30.77 11.54 NT 25.00 75.00 0.00 9.09 90.91 0.00
Tetracycline 100.00 0.00 0.00 100.00 0.00 0.00 NT 18.18 54.55 27.27 0.00 42.86 57.14
Erythromycin 42.86 21.43 35.71 94.59 0.00 5.41 100.00 0.00 0.00 14.52 50.00 35.48 5.88 82.35 11.76
Tilmicosin 0.00 82.35 17.65 90.48 7.14 2.38 100.00 0.00 0.00 12.82 85.90 1.28 0.00 77.78 22.22
Florfenicol 0.00 100.00 0.00 11.90 88.10 0.00 0.00 100.00 0.00 2.56 97.44 0.00 0.00 100.00 0.00
Lincomycin 64.71 17.65 17.65 95.24 4.76 0.00 NT 61.54 15.38 23.07 0.00 61.11 38.89
Sulfadiazine + 
trimethoprim
11.76 88.24 0.00 40.48 57.14 2.38 100.00 0.00 0.00 20.51 69.23 23.07 0.00 61.11 38.89
aResistant (R); bIntermediate (I); cSusceptible (S); dNot tested (NT).
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Table 3. Percentage of bacterial isolates isolated from pigs with respiratory clinical signs tested for each antimicrobial, 2006-2007, Brazil
Antimicrobial
Isolates tested (%)*
Ap (n=17) Ss (n=42) Bb (n=5) Pm (n=78) Hp (n=18)
Amoxicillin 88.24 100.00 100.00 100.00 100.00
Ceftiofur 100.00 100.00 NT 100.00 100.00
Ciprofloxacin 88.24 100.00 100.00 100.00 100.00
Chlortetracycline 64.71 61.90 NT 71.79 61.11
Doxycycline 100.00 100.00 NT 100.00 100.00
Enrofloxacin 100.00 100.00 100.00 100.00 100.00
Erythromycin 82.35 88.10 100.00 80.77 94.44
Florfenicol 100.00 100.00 100.00 100.00 100.00
Lincomycin 100.00 100.00 NT 100.00 100.00
Oxytetracycline 64.71 61.90 NT 71.79 61.11
Sulfadiazine + trimethoprim 100.00 100.00 100.00 100.00 100.00
Penicillin 100.00 100.00 100.00 100.00 100.00
Tetracycline 41.18 38.10 NT 28.21 38.89
Tilmicosin 100.00 100.00 100.00 100.00 100.00
*Actinobacillus pleuropneumoniae (Ap); Streptococcus suis (Ss); Bordetella bronchiseptica (Bb); Pasteurella multocida (Pm); Haemophillus parasuis (Hp).
Figure 1. Antimicrobial susceptibility profiles of Actinobacillus pleuropneumoniae, Haemophilus parasuis, Streptococcus suis, 
Bordetella bronchiseptica, and Pasteurella multocida isolated from pigs with respiratory clinical signs in nine states of 
midweast, southeast and south of Brazil, from May 2006 to November 2007. Penicillins (PV), Cephalosporins (CEF), 
Quinolones (QUI), Tetracyclines (TE), Macrolides (MAC), Anfenicois (ANF), Lincosamides (LNC), Folate Pathway 
Inhibitors (IF), and Diterpenoids (DIF).
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antimicrobials (Table 2) tested and were classified as MDR. 
A total of 50 [50/160 (31.25%)] of all isolates were considered 
MDR. The frequency of MDR strains by bacterial species 
is shown in Table  4. Midwestern and southern regions 
exhibited significantly higher proportion of MDR isolates, 
86.21% and 78.57%, respectively, compared to southeastern 
region (22.73%) (Chi-square χ2 = 13.5189; P = 0.0011). 
Isolates from the southeastern region exhibited about 70% 
less chance to be classified as MDR compared to isolates 
from the midwestern [Odds ratio (OR) = 0.2636; 95% 
confidence interval (CI): 0.1215 to 0.5722] and southern 
(OR = 0.2893; 95% CI: 0.1092 to 0.7858) regions. In contrast, 
no association between resistance profile and the season 
sampling was observed.
Discussion
The establishment of the frequency of the bacterial 
pathogens associated with porcine respiratory disease in 
Brazil was not the aim of this study, but results obtained 
reflect the frequency of the most common bacterial pathogens 
associated with respiratory clinical disorders in swine 
raised worldwide. Therefore, it was possible to draw several 
conclusions about the antimicrobial susceptibility profile 
of the isolates and, especially, about the high frequency of 
MDR isolates observed in the sampling, mainly among 
S. suis and B. bronchiseptica. Moreover, the obtained results 
pointed to a significant level of resistance to lincomycin, 
erythromycin, sulfadiazine/trimethoprim, and tetracycline 
among bacterial respiratory pathogens isolated.
Compared with other species, H. parasuis showed 
a different resistance profile (Figure  2), being highly 
resistant to sulfadiazine/trimethoprim. Similar results 
were observed in China where a high level of resistance to 
sulfonamides (44.5%) were also found among H. parasuis 
clinical isolates (Zhou et al., 2010). The high resistance to 
sulfadiazine/trimethoprim found by Zhao et al. (2018) could 
be related to the presence of sul1 and sul2 genes, which 
has been associated with sulfonamide resistance in this 
Table 4. Frequency of multidrug resistance (MDR) among bacterial isolates from pigs with respiratory clinical signs in nine different 
states of midweast, southeast and south of Brazil; between May 2006 and November 2007
Bacteria Species Total of Isolates
MDR Strains
Number Percentage
Pasteurella multocida 78 14 17.95
Streptococcus suis 42 26 61.90
Haemophilus parasuis 18 1 5.55
Actinobacillus pleuropneumoniae 17 4 23.52
Bordetella bronchiseptica 5 3 60.00
Total 160 50 30.00
Figure 2. Resistance profiles of Pasteurella multocida, Streptococcus suis, Actinobacillus pleuropneumoniae and Haemophilus 
parasuis isolated from pigs with respiratory clinical signs to different antimicrobial groups in Midwest, Southeast, and 
South regions of Brazil, between May 2006 and November 2007. The diameter of the circles is proportional to the 
percentage of strains in the region classified as resistant.
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species. S. suis, in turn, showed high resistance to several 
drugs (mainly macrolides and tetracyclines) and half of 
the isolates were MDR (Table 2 and Figure 1), which were 
distributed among all studied regions (Figure 2). Similar 
studies also revealed high levels of resistance among S. suis, 
mainly to tetracycline (Portis & Lindeman, 2013; Jong et al., 
2014). The high levels of resistance for this pathogen have 
been associated with the massive use of antimicrobials in 
swine, which is especially important considering that this 
agent is an important zoonotic pathogen (Palmieri et al., 
2011). At that, the high number of MDR strains and the 
wide distribution of S. suis in the regions from where the 
samples were collected are very alarming, since these strains 
can infect humans. Moreover, S. suis infections are difficult 
to track, representing an important link between human 
and animal health.
Likewise, although the distribution is not as wide as that of 
S. suis, the resistance levels found in B. bronchiseptica isolated 
in Brazil is also disturbing. Many resistant B. bronchiseptica 
strains isolated from pigs were also observed by Dayao et al. 
(2014) in Australia. Furthermore, it is important to 
take into account that the majority of the resistance 
genes found in this pathogen are localized in plasmids, 
and B. bronchiseptica-induced infections are frequently 
associated with coinfections (mainly with P. multocida) 
(Opriessnig et al., 2011; Kadlec & Schwarz, 2018; Niemann et al., 
2018). The polymicrobial environment of the coinfections 
can facilitate the gene transference between strains, even 
to other species, which may explain the results observed in 
the present study, as well as results obtained in Australia. 
Therefore, it is important to highlight that B. bronchiseptica 
is a relevant pathogen in respiratory diseases in swine, since, 
in addition to its ability to acquire resistance genes, it may 
still be the source of resistance gene to other species, such 
as P. multocida and A. pleuropneumoniae (Furian et  al., 
2016), which are commensal bacteria in swine respiratory 
tract. Indeed, we observed high levels of resistance in these 
species (P. multocida and A. pleuropneumoniae), mainly to 
lincomycin and tetracycline. Similar results were observed 
in other studies performed in China, Australia, and Europa 
(Tang et al., 2009; Dayao et al., 2014; Jong et al., 2014), 
suggesting that resistance to tetracycline and lincomycin 
is widespread among swine.
The use of antimicrobials as growth promoters is usually 
incriminated as one of the main causes for the emerging 
high number of resistant bacteria (S. suis, for instance), 
which has major public health consequences. However, 
as secondary data registered in the present study, it is not 
possible to determine whether bacterial isolates were from 
swine exposed to antimicrobial treatment, although this is 
highly likely since this practice was very common in Brazil 
at the sampling time. Moreover, it is tempting to speculate 
that the use of antimicrobials as growth promoters, despite 
being frequent throughout the country, was less frequent in 
pig farms from the southeastern region, since a significantly 
lower level of resistance among bacterial isolates from this 
region was observed in comparison with strains from the 
other regions. At present, this practice is still frequent in 
Brazil (Dutra, 2017), although some antimicrobials are 
now forbidden to be used as growth promoters, and some 
farms have completely abolished the use of antimicrobials 
in pig production.
In Brazil, records on the sale of antimicrobials for 
animal use are not available, mainly for animal production. 
Consequently, there are inconsistent data on the drugs most 
commonly used as growth promoters and those that are used 
to prevent diseases in pig farming. Furthermore, there are 
only a few studies on antimicrobial resistance in bacteria 
isolated from pigs with respiratory diseases in this country. 
The absence of these information precludes the direct causal 
association between the high levels of resistance observed 
and the major antimicrobials used in pig production, in 
addition to substantial comparisons between the results 
obtained in this study and in other countries. However, an 
investigation performed in 25 pig farms in Brazil showed 
that the lincosamide class was used in 52.0%, macrolides in 
48.0%, and tetracyclines in 80.0% of the pig farms assessed 
(Dutra, 2017). Furian et al. (2016), also in Brazil, found 
high levels of resistance to tetracycline, folate inhibitors 
and erythromycin in P. multocida, suggesting that these 
resistance profiles may be frequent among pulmonary bacteria 
from Brazilian pig herds. In addition, even indirectly, the 
obtained results can also be compared with those found in 
countries with swine production systems similar to the one 
observed in Brazil, allowing the inference that the resistance 
to lincomycin, sulfadiazine/trimethoprim, and tetracycline 
classes observed in the present investigation are very likely 
due to the use of these drugs as growth promoters. In fact, in 
China, Tang et al. (2009) also found resistance to lincomycin, 
sulfadiazine/trimethoprim, and tetracyclines in P. multocida 
isolated from swine. Similarly, Dayao et al. (2014, 2016) in 
Australia and Portis & Lindeman (2013), in Canada and 
the United States, also observed resistance to tetracycline 
among porcine respiratory pathogens. Moreover, Carlson 
& Fangman (2000) mentioned that, in the United States, 
sulfadiazine/trimethoprim and tetracyclines are commonly 
used as growth promoters, as well as lincomycin, which is 
also used to prevent diseases.
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In contrast, in Europe, the use of antimicrobials as 
growth promoters has been prohibited since 2003. Even so, 
recent studies performed in European countries revealed 
strains resistant to tetracycline and higher values of minimal 
inhibitory concentration to lincomycin, suggesting that 
the consequences of using antimicrobials persist even after 
years of abstinence (Jong et al., 2014; El Garch et al., 2016). 
The most important cost of the reckless use of antimicrobials 
is the emergence of MDR bacteria, which are a potential 
risk to public health (Landers  et  al., 2012; Jong  et  al., 
2014). Hence, there has been an important decrease in 
the number of countries worldwide that allow the use of 
antimicrobials as growth promoters (World Organisation 
for Animal Health, 2016). The high number of MDR and 
their widespread distribution in the three Brazilian regions, 
which concentrate the country pig production (Associação 
Brasileira de Proteína Animal, 2018) (Figure 2) observed 
in this study, highlights the importance of the careful use 
of antimicrobials in animal production. Brazil is a major 
producer and exporter of swine and, due to the demands 
of importing countries, the use of antimicrobials in animal 
production has been increasingly controlled and many 
antimicrobial groups (tylosin, lincomycin, virginiamycin, 
bacitracin and tiamulin) considered important in human 
medicine were recently abolished by law (Ministério da 
Agricultura, Agropecuária e Abastecimento, 2018). Although 
the present results reflected the reality of a decade ago, they 
are very alarming, since most of the strains were resistant 
to at least one antimicrobial agent (98.75%, 158/160) and 
31.25% (50/160) of the strains were MDR. Currently, 
bacterial resistance status is probably very similar or even 
worse, since the use of antimicrobials as growth promoters 
are still frequent and were intensively used through these 
years. Therefore, the obtained results reinforce the need 
for abolition of this practice in all countries, as well as the 
need for finding safe and effective alternatives to protect 
public and animal health. Indeed, some alternatives have 
been developed, such as probiotics, prebiotics, organic acids, 
enzymes, and modifiers of microbial activity (Santana et al., 
2015).
Conclusions
Overall, the results of the present study showed a 
great level of resistance to lincomycin, erythromycin, 
sulfadiazine/trimethoprim, and tetracycline among 
bacterial respiratory pathogens isolated from pigs in Brazil. 
Moreover, MDR was also observed in an extensive amount 
of the isolates, with particularly high percentages among 
B. bronchiseptica and S. suis strains.
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